Swedish Orphan Biovitrum AB (SWOBY) announced earnings for its fourth quarter that Increases, from the same period last year
The company's bottom line totaled SEK1.861 billion, or SEK5.34 per share. This compares with SEK1.397 billion, or SEK4.02 per share, last year.
Excluding items, Swedish Orphan Biovitrum AB reported adjusted earnings of SEK5.65 per share for the period.
The company's revenue for the period rose 5.2% to SEK7.821 billion from SEK7.436 billion last year.
Swedish Orphan Biovitrum AB earnings at a glance (GAAP) :
-Earnings: SEK1.861 Bln. vs. SEK1.397 Bln. last year.-EPS: SEK5.34 vs. SEK4.02 last year.-Revenue: SEK7.821 Bln vs. SEK7.436 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.